IP Library Granted Patent US 11,247,044
Granted Patent B2
US 11,247,044 · App. 16/687,576 · Granted Feb 15, 2022

Devices for delivering neuroregenerative therapy

Inventors: Michael Patrick Willand (Oakville, CA); Sergio David Aguirre (Bolton, CA)
Assignee: Epineuron Technologies Inc.
A61N1/0556A61N1/0492A61N1/36125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,247,044
App. No.
16/687,576
Granted
Feb 15, 2022
Kind
B2
Abstract

Systems, devices and methods are disclosed for the treatment of injured peripheral nerves or other tissue using electrical stimulation. The systems can be used either in intraoperative or peri-operative settings and incorporate the use of either a plurality of monopolar electrodes with a patch used as return or a plurality of bipolar electrodes such as a cuff. The systems can provide hands-free delivery of electrical stimulation therapy over a predetermined set of time.

Claims (45)

1. A device for stimulating a target nerve of a subject, comprising:

a lead; and

at least one electrode electrically coupled to the lead;

wherein during a verification phase, the device is configured to deliver stimulation energy having a first frequency to the target nerve of the subject via the at least one electrode; and

during a therapeutic phase, the device is configured to deliver stimulation energy having a second frequency to the target nerve of the subject for a predetermined time period via the at least one electrode,

wherein the delivery of stimulation energy during the verification phase is configured to confirm at least one condition, wherein the at least one condition comprises measurement of at least one electrical parameter at a location upstream to an injury site of the target nerve, wherein the at least one electrical parameter is associated with the target nerve;

wherein the delivery of stimulation energy to the subject during the therapeutic phase creates a regenerative effect to the target nerve;

wherein the second frequency is equal to or greater than the first frequency; and

wherein the lead is configured to be advanced to or near the target nerve through a skin surface of the subject via a para-incisional pathway, wherein the para-incisional pathway is percutaneous and is separate of an opening of the skin surface related to the injury site of the target nerve of the subject.

2. The device of claim 1 ,

wherein the at least one electrical parameter comprises action potentials in the target nerve;

wherein the second frequency is 10 Hz to 100 Hz; and

wherein the delivery of stimulation energy during the verification phase is configured to activate an indicator as a confirmation of the at least one condition.

3. The device of claim 1 , wherein the verification phase is a separate event from the therapeutic phase.

4. The device of claim 1 , wherein the verification phase and the therapeutic phase comprise a single event.

5. The device of claim 1 , wherein the at least one electrical parameter comprises action potentials in the target nerve.

6. The device of claim 1 , wherein the delivery of stimulation energy during the verification phase is configured to activate an indicator confirming a confirmation of the at least one condition.

7. The device of claim 1 , wherein the at least one electrical parameter comprises current flow.

8. A device for stimulating a target nerve of a subject, comprising:

a lead; and

at least one electrode electrically coupled to the lead;

wherein at least one condition is configured to be confirmed by a delivery of stimulation energy to the subject via at least one electrode, wherein the at least one condition comprises measurement of at least one electrical parameter at a location upstream to an injury site of the target nerve, the at least one electrical parameter being associated with the target nerve;

wherein the device is configured to deliver stimulation energy having a frequency to the target nerve of the subject for a predetermined time period via the at least one electrode;

wherein the delivery of stimulation energy to the subject at the frequency for the predetermined time period is configured to create a regenerative effect to the target nerve;

wherein the frequency is 10 Hz to 100 Hz; and

wherein the device is configured to activate an indicator when there is confirmation of the at least one condition,

wherein the lead is configured to be advanced to or near the target nerve through a skin surface of the subject via a para-incisional pathway, wherein the para-incisional pathway is percutaneous and is separate of an opening of the skin surface related to the injury site of the target nerve of the subject.

9. The device of claim 8 , wherein the at least one condition comprises a measurement of action potentials in the target nerve.

10. The device of claim 8 , wherein the delivery of stimulation energy to confirm at least one condition is a separate event from a delivery of stimulation energy to create a regenerative effect.

11. The device of claim 8 , wherein the delivery of stimulation energy to confirm at least one condition and the delivery of stimulation energy to create a regenerative effect are a single event.

12. The device of claim 8 , wherein the at least one electrical parameter comprises current flow.

13. A device for stimulating a target nerve of a subject, comprising:

a lead; and

at least one electrode electrically coupled to the lead;

a lead electrically coupled to the at least one electrode;

wherein the device is configured to deliver stimulation energy to the subject via the at least one electrode to confirm at least one condition, wherein the at least one condition comprises measurement of at least one electrical parameter associated with a delivery of stimulation energy to the target nerve at a location upstream to an injury site of the target nerve;

wherein a delivery of stimulation energy to the subject at a frequency for a predetermined time period is configured to create a regenerative effect to the target nerve;

wherein a delivery of stimulation energy to confirm the at least one condition is configured to activate an indicator confirming a confirmation of the at least one condition; and

wherein the lead is configured to be advanced to or near the target nerve through a skin surface of the subject via a para-incisional pathway, wherein the para-incisional pathway is percutaneous and is separate of an opening of the skin surface related to the injury site of the target nerve of the subject.

14. The device of claim 13 , wherein the at least one condition comprises a measurement of action potentials in the target nerve.

15. The device of claim 13 , wherein a delivery of stimulation energy to confirm at least one condition is a separate event from delivering stimulation energy to create a regenerative effect.

16. The device of claim 13 , wherein a delivery of stimulation energy to confirm at least one condition and delivering stimulation energy to create a regenerative effect are a single event.

17. The device of claim 13 , wherein the at least one electrical parameter comprises current flow.

18. The device of claim 13 , wherein the opening of the skin surface related to the injury site comprises a laceration.

19. The device of claim 13 , wherein the opening of the skin surface related to the injury site comprises an incision.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2019
From: WILLAND, MICHAEL PATRICK; AGUIRRE, SERGIO DAVID
To: EPINEURON TECHNOLOGIES INC.
Reel/Frame 051054/0557 →
Continuity (6)
Continuation 16553043 · Aug 27, 2019
Continuation In Part PCTUS2018057375 · Oct 24, 2018
Provisional Application 62577141 · Oct 25, 2017
Provisional Application 62683019 · Jun 11, 2018
Provisional Application 62849833 · May 17, 2019
Related Publication 20200086114A1 · Mar 19, 2020
Cited By (3)
US 12,318,608 US 12,611,538 US 12,616,832